Paul Tudor Jones’s Kura Oncology KURA Stock Holding History

Paul Tudor Jones’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$477K	Hold	43,520	–	–	﹤0.01%	2855
2026 Q1	$354K	Sell	43,520 -500	-1%	-$4.29K	﹤0.01%	3043
2025 Q4	$457K	Buy	+44,020	New	+$462K	﹤0.01%	2769
2025 Q1	–	Sell	-38,805	Closed	-$338K	–	3356
2024 Q4	$338K	Buy	+38,805	New	+$558K	﹤0.01%	2513
2023 Q3	–	Sell	-34,839	Closed	-$369K	–	2599
2023 Q2	$369K	Buy	+34,839	New	+$412K	﹤0.01%	1884
2022 Q1	–	Sell	-36,843	Closed	-$516K	–	2377
2021 Q4	$516K	Buy	+36,843	New	+$597K	0.01%	1443
2021 Q1	–	Sell	-12,316	Closed	-$402K	–	1723
2020 Q4	$402K	Buy	+12,316	New	+$433K	0.01%	1024
2019 Q3	–	Sell	-17,901	Closed	-$352K	–	1225
2019 Q2	$352K	Buy	+17,901	New	+$297K	0.01%	821

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Paul Tudor Jones's KURA Position: Q2 2026 in Review

Paul Tudor Jones held its Kura Oncology (KURA) position steady in Q2 2026 at 43,520 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Paul Tudor Jones first reported a position in KURA in Q2 2019 and has held it in 8 quarters since. The position peaked at $516K in Q4 2021. 219 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Paul Tudor Jones held 43,520 shares of Kura Oncology worth $477K as of Q2 2026.
Paul Tudor Jones left its Kura Oncology share count unchanged in Q2 2026.
Kura Oncology made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2855 holding.
Paul Tudor Jones first reported a position in Kura Oncology in Q2 2019 and has held it in 8 quarters since.
Paul Tudor Jones's Kura Oncology position peaked at $516K in Q4 2021.
219 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.